Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hevea brasiliensis allergens are a group of proteins found in the natural rubber latex (NRL) harvested from the Para rubber tree. These proteins, designated Hev b 1 through Hev b 15 by the WHO/IUIS Allergen Nomenclature Sub-Committee, serve various physiological roles in the plant, including defense against pathogens and stabilization of rubber particles (WHO/IUIS, 2024; Raulf, 2020). In humans, these allergens are the primary cause of latex allergy, a Type I hypersensitivity reaction mediated by immunoglobulin E (IgE) (Baur et al., 2015). Exposure can occur through direct skin contact, inhalation of powder from latex gloves, or mucosal contact during medical procedures, leading to symptoms ranging from contact urticaria to life-threatening anaphylaxis (Pariyaprasert et al., 2023). In the pharmaceutical context, these allergens are the targets for diagnostic assays and allergen-specific immunotherapy (AIT), which seeks to desensitize the immune system through controlled exposure to allergen extracts (Raulf, 2020). Additionally, certain latex allergens share structural homology with proteins in fruits like bananas and avocados, leading to the clinically significant latex-fruit syndrome (Wagner and Breiteneder, 2002).
Allergen-specific immunotherapy (AIT) induces immune tolerance by promoting regulatory T-cell (Treg) activity and shifting the immune response from a Th2-mediated IgE production to a Th1/Treg-mediated IgG4 production (Raulf, 2020; Pariyaprasert et al., 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hevea brasiliensis allergens (NRL allergens).